Clinical Trial Update: Troriluzole in Adult Participants With Spinocerebellar Ataxia [Phase 3]

View source ↗

Summary

Phase 3 trial update for troriluzole in adults with spinocerebellar ataxia indicating ongoing status with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia
• Spinocerebellar Ataxia Type
• Spinocerebellar Ataxia Type 1
• Spinocerebellar Ataxia Type 10
• Spinocerebellar Ataxia Type 2
• Spinocerebellar Ataxia Type 3
• Spinocerebellar Ataxia Type 7
• Spinocerebellar Ataxia Type 8

Drugs mentioned

• Troriluzole (troriluzole)

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-10